AI Summary & Key Takeaways
AI InsightS100A8/S100A9 level was positively correlated with LOOH, TOS and OSI levels but negatively correlated with -SH level in the patients with AITD.Conclusion: Serum S100A8/S100A9 levels were increased in patients with AITD and positively correlated with LOOH, TOS and OSI whereas negatively correlated with SH
📌 3 Key Takeaways
Abstract
Background: The correlation of S100A8/S100A9 with various inflammatory conditions, including autoim-mune diseases have been reported. There is no study investigating the levels of S100A8/S100A9 in autoim-mune thyroid diseases (AITD)Aims: We aimed to evaluate the level of serum S100A8/S100A9 in AITD.Study Design: Case control study.Methods: Fifty patients with AITD (25 Hashimoto's thyroiditis (HT) and 25 Graves' disease (GD)) were included in the study. Twenty seven healthy subjects participated as a control group. Blood samples were obtained in the 3 months after the initiation of medi-cal treatment. Serum levels of total antioxidant status (TAS), total oxidative status (TOS), total free sulfhy-dryl (SH), lipid hydroperoxide (LOOH) and S100A8/S100A9 were analyzed. Results: The patients with AITD had significantly higher S100A8/S100A9, OSI, LOOH and TOS levels than the healthy control group. There was no signifi-cant difference between GD and HT patients in terms of S100A8/S100A9, TOS and OSI levels. S100A8/S100A9 level was positively correlated with LOOH, TOS and OSI levels but negatively correlated with -SH level in the patients with AITD.Conclusion: Serum S100A8/S100A9 levels were increased in patients with AITD and positively correlated with LOOH, TOS and OSI whereas negatively correlated with SH